Baylor Scott & White Medical Center in Temple has opened enrollment on a study designed to help characterize the prevalence and distribution of lipoprotein(a) Lp(a), levels among patients with established cardiovascular disease (CVD).
Baylor Scott & White Medical Center in Temple has opened enrollment on a study designed to help characterize the prevalence and distribution of lipoprotein(a) Lp(a), levels among patients with established cardiovascular disease (CVD).
Baylor Scott & White Heart & Vascular Hospital – Dallas is currently enrolling patients for a prospective, multicenter, single-arm, global investigational device exemption (IDE) study to evaluate the safety and effectiveness of the Shockwave Coronary IVL System in de novo, calcified, stenotic coronary arteries prior to stenting. Disrupt CAD III is being conducted as a staged pivotal study.
Baylor Scott & White All Saints Medical Center – Fort Worth is currently enrolling patients for a study designed to assess the impact of the Multi Point Pacing (MPP) feature at 12 months in the treatment of patients not responding to standard Cardiac Resynchronization Therapy (CRT) after 6 months.
Despite the availability of pulmonary arterial hypertension (PAH)-targeted therapeutic options over the past twenty years, there is general consensus around shortcomings with regards to PAH diagnosis and management.
New research in the International Journal of Nursing Studies examines the effect of an Early Warning Score-guided proactive rapid response team model on the frequency of unplanned intra-hospital escalations in care.